Shaff Eric D.'s Form 4 filing
Seres Therapeutics, Inc. (MCRB) · filed Feb 19, 2025
- Accession no.
- 0000950170-25-023575
- Filed
- Feb 19, 2025
- Trade date
- Feb 15-18, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shaff Eric D.CIK 0001643734 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | Common Stock | MOption exerciseAcquired | +7,813 | – | – | 178,202 | Direct | |
| Feb 15, 2025 | Common Stock | MOption exerciseAcquired | +26,563 | – | – | 204,765 | Direct | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −12,726 | $0.81 | −$10,308.06 | 192,039 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | Common Stock | MOption exerciseDisposed | −7,813 | $0.00 | $0 | 62,500 | Direct | |
| Feb 15, 2025 | Common Stock | MOption exerciseDisposed | −26,563 | $0.00 | $0 | 79,687 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.